As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Moderator(s)

William Schaffner, MD

Professor of Preventive Medicine and Infectious Diseases, Department of Health Policy, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee

Disclosures

Disclosure: William Schaffner, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Dynavax Technologies Corporation; GlaxoSmithKline; Merck & Co., Inc.; Novavax, Inc.; Pfizer Inc.; Sanofi Pasteur SMD
Served as a speaker or a member of a speakers bureau for: Genentech, Inc.

Dr Schaffner does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Schaffner does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Presenter(s)

Andrea Freyer Dugas, MD

Assistant Professor of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Disclosures

Participation by Dr Dugas does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: Andrea Freyer Dugas, MD, has disclosed no relevant financial relationships.

Dr Dugas does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Dugas does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Frederick S. Nolte, PhD

Professor; Vice Chair for Laboratory Medicine; Medical Director of Clinical Laboratories, Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina

Disclosures

Disclosure: Frederick S. Nolte, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: bioMerieux, Inc.
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; BioFire Diagnostics
Received grants for clinical research from: Alere; Roche

Dr Nolte does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Nolte does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Susan L. Smith, MN, PhD

Lead Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC

Disclosures

Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

CME / ABIM MOC / CE

Is it the Flu? Advances in Diagnostic Strategies and Implications for Patient Care

Authors: William Schaffner, MD; Andrea Freyer Dugas, MD; Frederick S. Nolte, PhD
CME / ABIM MOC / CE Released: 12/22/2016; Reviewed and Renewed: 2/15/2018
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 2/15/2019, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for primary care physicians, emergency medicine physicians, obstetricians & gynecologists, and ID/HIV specialists.

The goal of this activity is to educate clinicians on the use of antigen-based and molecular-based point of care rapid influenza tests.

Upon completion of this activity, participants will:

Have increased knowledge regarding:
1. When testing for influenza can provide benefit in establishing a diagnosis
2. Advantages and disadvantages of rapid antigen tests and newer rapid molecular tests incorporating PCR for the diagnosis of flu
3. The potential role of rapid molecular tests in antibiotic stewardship and/or overall patient care decisions

Disclosures

Moderator(s)

William Schaffner, MD

Professor of Preventive Medicine and Infectious Diseases, Department of Health Policy, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee

Disclosures

Disclosure: William Schaffner, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Dynavax Technologies Corporation; GlaxoSmithKline; Merck & Co., Inc.; Novavax, Inc.; Pfizer Inc.; Sanofi Pasteur SMD
Served as a speaker or a member of a speakers bureau for: Genentech, Inc.

Dr Schaffner does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Schaffner does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Presenter(s)

Andrea Freyer Dugas, MD

Assistant Professor of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Disclosures

Participation by Dr Dugas does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: Andrea Freyer Dugas, MD, has disclosed no relevant financial relationships.

Dr Dugas does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Dugas does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Frederick S. Nolte, PhD

Professor; Vice Chair for Laboratory Medicine; Medical Director of Clinical Laboratories, Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina

Disclosures

Disclosure: Frederick S. Nolte, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: bioMerieux, Inc.
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; BioFire Diagnostics
Received grants for clinical research from: Alere; Roche

Dr Nolte does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Nolte does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Susan L. Smith, MN, PhD

Lead Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC

Disclosures

Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Accreditation Statements

Medscape, LLC is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: 0461-0000-16-220-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Family Medicine

CME / ABIM MOC / CE

Is it the Flu? Advances in Diagnostic Strategies and Implications for Patient Care

Authors: William Schaffner, MD; Andrea Freyer Dugas, MD; Frederick S. Nolte, PhDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 12/22/2016; Reviewed and Renewed: 2/15/2018

Valid for credit through: 2/15/2019, 11:59 PM EST

processing....

CME / ABIM MOC / CE Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Moderator(s)

William Schaffner, MD

Presenter(s)

Andrea Freyer Dugas, MD

Frederick S. Nolte, PhD

Editor(s)

Susan L. Smith, MN, PhD

CME Reviewer/Nurse Planner

Amy Bernard, MS, BSN, RN-BC

CME / ABIM MOC / CE

Is it the Flu? Advances in Diagnostic Strategies and Implications for Patient Care

Target Audience and Goal Statement

Disclosures

Moderator(s)

William Schaffner, MD

Presenter(s)

Andrea Freyer Dugas, MD

Frederick S. Nolte, PhD

Editor(s)

Susan L. Smith, MN, PhD

CME Reviewer/Nurse Planner

Amy Bernard, MS, BSN, RN-BC

Accreditation Statements

For Physicians

For Nurses

For Pharmacists

Instructions for Participation and Credit

Is it the Flu? Advances in Diagnostic Strategies and Implications for Patient Care